ArticleRSC advances2022
The effect of hydrophobic chains on retarding performance of retarding acids.
Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acidizing retarders are used to reduce the reaction rate between hydrochloric acid (HCl) and carbonates to increase the efficiency of acidification of oil and gas wells and increase oil and gas recovery. We synthesized two polymeric acidizing retarders (AR-1 and AR-2) to explore ways to improve the efficiency of this process. Retarder AR-1 is based on acrylamide (AM) and allyl polyethylene glycol (APEG-1000), and retarder AR-2 is composed of AM, APEG-1000, and octadecyl dimethyl allyl ammonium chloride (C-18). The molecular structures of AR-1 and AR-2 were characterized by Fourier transform infrared (FT-IR) and
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.